Accueil › Surpoids › Californie

Essais cliniques pour Surpoids dans Californie

63 études pour Surpoids recherchent des participants dans Californie.

Villes dans Californie

Texte officiel de l'étude (anglais)

A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight

Neighborhood Healthcare, Escondido

Recrutement en coursPhase 3

Âges de 8 à 18 · Tous sexes · Mis à jour le 30 sept. 2026 · NCT07253285

AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight

Torrance Clinical Research Institute, Inc., Lomita
Diablo Clinical Research, Inc., Walnut Creek

Recrutement en coursPhase 3

Âges de 18 ans et plus · Tous sexes · Mis à jour le 30 sept. 2026 · NCT07533175

Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes

Diablo Clinical Research - Flourish Research, Walnut Creek

Recrutement en coursPhase 2

Âges de 18 ans et plus · Tous sexes · Mis à jour le 29 sept. 2026 · NCT07685808

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

John Muir Health - Concord /ID# 282469, Concord
NorCal Medical Research /ID# 283117, Greenbrae
Los Angeles Institute for Metabolic Research /ID# 282059, Los Angeles
et 4 autres

Recrutement en coursPhase 2

Âges de 18 à 75 · Tous sexes · Mis à jour le 29 sept. 2026 · NCT07752979

AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight

Providence Medical Foundation, Fullerton
Torrance Clinical Research Institute, Inc., Lomita
Diablo Clinical Research, Inc., Walnut Creek

Recrutement en coursPhase 3

Âges de 18 ans et plus · Tous sexes · Mis à jour le 28 sept. 2026 · NCT07720271

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

San Fernando Valley Health Institute, Canoga Park
Headlands Research California, LLC, Escondido
ImmuniMet, LLC, Modesto
et 4 autres

Recrutement en coursPhase 3

Âges de 18 ans et plus · Tous sexes · Mis à jour le 28 sept. 2026 · NCT07595549

Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss

Profound Research, Oceanside

Recrutement en coursPhase 2

Âges de 18 à 75 · Tous sexes · Mis à jour le 28 sept. 2026 · NCT07837973

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

First Valley Medical Group, Lancaster
Desert Oasis Healthcare, Palm Springs
Western University of Health Sciences, Pomona
et 1 autres

Recrutement en coursPhase 3

Âges de 18 ans et plus · Tous sexes · Mis à jour le 28 sept. 2026 · NCT07668414

A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

Orange County Research Center, Lake Forest
Healthy Brain Clinic, Long Beach
Los Angeles Institute for Metabolic Research, Los Angeles
et 6 autres

Recrutement en coursPhase 3

Âges de 18 ans et plus · Tous sexes · Mis à jour le 28 sept. 2026 · NCT07794579

Safety and Drug Concentrations of REGN20934 in Adults With Overweight or Obesity

Parexel International, Glendale

Recrutement en coursPhase 1Volontaires sains bienvenus

Âges de 18 à 65 · Tous sexes · Mis à jour le 25 sept. 2026 · NCT07594093

A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus

Research Site, Escondido
Research Site, Lincoln
Research Site, Walnut Creek

Recrutement en coursPhase 3

Âges de 18 ans et plus · Tous sexes · Mis à jour le 25 sept. 2026 · NCT07776509

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

Loma Linda University School of Medicine, Loma Linda
Childrens Hospital of Los Angeles, Los Angeles
UCLA Mattel Children's Hospital, Los Angeles
et 2 autres

Recrutement en coursPhase 3

Âges de 6 à 17 · Tous sexes · Mis à jour le 24 sept. 2026 · NCT06672549

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

Smart Cures Clinical Research, Anaheim
Cedars-Sinai Medical Center, Beverly Hills
United Medical Doctors - Los Alamitos, Los Alamitos
et 1 autres

Recrutement en coursPhase 3

Âges de 18 à 70 · Tous sexes · Mis à jour le 24 sept. 2026 · NCT06937086

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

Smart Cures Clinical Research, Anaheim
Cedars-Sinai Medical Center, Beverly Hills
United Medical Doctors - Los Alamitos, Los Alamitos
et 1 autres

Recrutement en coursPhase 3

Âges de 18 à 70 · Tous sexes · Mis à jour le 24 sept. 2026 · NCT06937099

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

San Fernando Valley Health Institute, Canoga Park
AMCR Institute, Escondido
NorCal Medical Research, Inc, Greenbrae
et 6 autres

Recrutement en coursPhase 3

Âges de 18 ans et plus · Tous sexes · Mis à jour le 22 sept. 2026 · NCT07282600

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Valley Clinical Trials, LLC dba Flourish Research, Covina
Velocity Clinical Research- Huntington Park, Huntington Park
Orange County Research Center, Lake Forest
et 5 autres

Recrutement en coursPhase 3

Âges de 45 à 99 · Tous sexes · Mis à jour le 22 sept. 2026 · NCT07037433

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

Ark Clinical Research - Fountain Valley, Fountain Valley
Wolverine Clinical Trials, Santa Ana
Encompass Clinical Research, Spring Valley
et 1 autres

Recrutement en coursPhase 3

Âges de 18 ans et plus · Tous sexes · Mis à jour le 22 sept. 2026 · NCT07353931

A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

Neighborhood Healthcare Institute of Health, Escondido
Ark Clinical Research - Fountain Valley, Fountain Valley
Desert Oasis Healthcare Medical Group, Palm Springs
et 4 autres

Recrutement en coursPhase 3

Âges de 18 ans et plus · Tous sexes · Mis à jour le 22 sept. 2026 · NCT07321886

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

Research Site, Bakersfield
Research Site, Gardena
Research Site, Lincoln
et 2 autres

Recrutement en coursPhase 3

Âges de 18 ans et plus · Tous sexes · Mis à jour le 22 sept. 2026 · NCT07784270

CHOICE to AVOID or RESIST

Cedars-Sinai Medical Center, Beverly Hills

Recrutement en coursVolontaires sains bienvenus

Âges de 18 à 80 · Tous sexes · Mis à jour le 22 sept. 2026 · NCT06521021

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

NorCal Medical Research, Inc, Greenbrae
Velocity Clinical Research, Huntington Park, Huntington Park
Peninsula Research Associates, Rolling Hills Estates
et 1 autres

Recrutement en coursPhase 2

Âges de 18 à 75 · Tous sexes · Mis à jour le 22 sept. 2026 · NCT07589608

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

Irvine Clinical Research, Irvine
Scripps Whittier Diabetes Institute, La Jolla
EndoTrials Center for Clinical Research, La Mesa
et 5 autres

Recrutement en coursPhase 3

Âges de 18 ans et plus · Tous sexes · Mis à jour le 22 sept. 2026 · NCT07392190

A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight

Ark Clinical Research, Long Beach
Collaborative Neuroscience Research, LLC, Los Alamitos
Artemis Institute for Clinical Research, Riverside

Recrutement en coursPhase 3

Âges de 18 ans et plus · Tous sexes · Mis à jour le 22 sept. 2026 · NCT07369011

A Study to Investigate the Effect of AZD6234, AZD9550, and a Combination of AZD9550 and AZD6234 on Pharmacokinetics of Combined Oral Contraceptive Ethinyl Estradiol/Levonorgestrel in Healthy Female Participants Living With Overweight or Obesity

Research Site, Glendale

Recrutement en coursPhase 1Volontaires sains bienvenus

Âges de 35 à 75 · Femmes · Mis à jour le 17 sept. 2026 · NCT07013643

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

AURORA-2 Clinical Site, Banning
AURORA-2 Clinical Site, Chula Vista
AURORA-2 Clinical Site, Covina
et 6 autres

Recrutement en coursPhase 3

Âges de 18 ans et plus · Tous sexes · Mis à jour le 16 sept. 2026 · NCT07743450

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

AURORA-1 Clinical Site, Banning
AURORA-1 Clinical Site, Chula Vista
AURORA-1 Clinical Site, Covina
et 5 autres

Recrutement en coursPhase 3

Âges de 18 ans et plus · Tous sexes · Mis à jour le 16 sept. 2026 · NCT07743463

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

Orange County Research Center, Lake Forest
Ark Clinical Research, Long Beach
Catalina Research Institute, LLC, Montclair
et 3 autres

Recrutement en coursPhase 3

Âges de 18 ans et plus · Tous sexes · Mis à jour le 14 sept. 2026 · NCT07351058

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

University of California Irvine, Irvine
Artemis Institute for Clinical Research, LLC, San Diego
Diablo Clinical Research, Inc., Walnut Creek

Recrutement en coursPhase 3

Âges de 18 ans et plus · Tous sexes · Mis à jour le 14 sept. 2026 · NCT07351045

A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide

Wolverine Clinical Trials, Santa Ana

Recrutement en coursPhase 2

Âges de 18 à 75 · Tous sexes · Mis à jour le 14 sept. 2026 · NCT06897475

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

ACCOMPLISH-2 Research Site, Escondido
ACCOMPLISH-2 Research Site, Fountain Valley
ACCOMPLISH-2 Research Site, La Jolla
et 4 autres

Recrutement en coursPhase 3Volontaires sains bienvenus

Âges de 18 à 79 · Tous sexes · Mis à jour le 11 sept. 2026 · NCT07654374

AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

Artemis Insitute for Clin Res, San Diego

Recrutement en coursPhase 3

Âges de 18 ans et plus · Tous sexes · Mis à jour le 11 sept. 2026 · NCT07571005

A Research Study Investigating How a New Medicine NNC0113-5840 Works in People With Overweight or Obesity

PAREXEL Glendale/LA EPCU, Glendale

Recrutement en coursPhase 1

Âges de 18 à 55 · Tous sexes · Mis à jour le 9 sept. 2026 · NCT07566390

Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight

Headlands Research California, LLC, Escondido
National Research Institute - Huntington Park, Huntington Park
Los Angeles Institute for Metabolic Research, Los Angeles

Recrutement en coursPhase 3

Âges de 18 ans et plus · Tous sexes · Mis à jour le 9 sept. 2026 · NCT07770841

Effects of Dietary Supplements on Muscle Mass and Function While Using GLP-1 Medication

UCLA Center for Human Nutrition, Los Angeles

Recrutement en coursVolontaires sains bienvenus

Âges de 18 ans et plus · Tous sexes · Mis à jour le 8 sept. 2026 · NCT07806838

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

NorCal Medical Research, Inc, Greenbrae
Velocity Clinical Research, Huntington Park, Huntington Park
Peninsula Research Associates, Rolling Hills Estates
et 1 autres

Recrutement en coursPhase 2

Âges de 18 à 75 · Tous sexes · Mis à jour le 8 sept. 2026 · NCT06143956

A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)

First OC Dermatology Research Inc, Fountain Valley
Center For Dermatology Clinical Research, Inc., Fremont
Metropolis Dermatology, Los Angeles
et 1 autres

Recrutement en coursPhase 4

Âges de 18 ans et plus · Tous sexes · Mis à jour le 4 sept. 2026 · NCT06857942

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

Kailera Clinical Site, Escondido
Kailera Clinical Site, La Mesa
Kailera Clinical Site, Montclair
et 3 autres

Recrutement en coursPhase 3

Âges de 18 ans et plus · Tous sexes · Mis à jour le 3 sept. 2026 · NCT07284901

Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes

Kailera Clinical Site, Escondido
Kailera Clinical Site, Toluca Lake

Recrutement en coursPhase 3

Âges de 18 ans et plus · Tous sexes · Mis à jour le 3 sept. 2026 · NCT07284875

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

Ark Clinical Research- Tustin, Fountain Valley
Long Beach Clinical Trials Services Inc, Long Beach
Ark Clinical Research- Long Beach, Long Beach
et 6 autres

Recrutement en coursPhase 3

Âges de 18 à 99 · Tous sexes · Mis à jour le 3 sept. 2026 · NCT07684235

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

San Fernando Valley Health Institute, Canoga Park
Core Healthcare Group, Cerritos
Velocity Clinical Research Chula Vista, Chula Vista
et 1 autres

Recrutement en coursPhase 3

Âges de 18 à 99 · Tous sexes · Mis à jour le 3 sept. 2026 · NCT07684144

Source : ClinicalTrials.gov, données récupérées le 1 oct. 2026. Chaque étude définit ses propres critères d'éligibilité ; l'équipe de l'étude décide qui peut y participer.